MAPK

Formononetin inhibits metastatic potential of human prostate cancer cells via upregulating EGR1

Liang X, Lan Z, Huang Y, Jiang G, Liu T. Formononetin inhibits metastatic potential of human prostate cancer cells via upregulating EGR1. Pharmacognosy Magazine [Internet]. 2022;18(80):932-939. http://www.phcog.com/text.asp?2022/18/80/932/361754

Sugemule-3 protects against isoprenaline-induced cardiotoxicity In vitro

Wang Y, Gong G-H, Xu Y-N, Yu L-J, Wei C-X. Sugemule-3 protects against isoprenaline-induced cardiotoxicity In vitro. Pharmacognosy Magazine [Internet]. 2017;13(51):517-522. https://www.ncbi.nlm.nih.gov/pubmed/28839382